ZBP1 pathway promotes tumor immunogenicity in the combination of anti-HER2 therapy and epigenetic therapy
Cell Reports · 2025-10 · 44 (10) · 116314
DOI: 10.1016/j.celrep.2025.116314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-10. Verfasst von Qishan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, State Key Laboratory of Innovative Immunotherapy, School of Pharmaceuti…. Hauptthemen laut MEDLINE: Epigenesis, Genetic, RNA-Binding Proteins, Erb-b2 Receptor Tyrosine Kinases, DNA-Binding Proteins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Jiao Tong University, Science and Technology Commission of Shanghai Municipality, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, State Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China.
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, State Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai 200240, China. E…
Förderung
- Shanghai Jiao Tong University
- Science and Technology Commission of Shanghai Municipality
- Fundamental Research Funds for the Central Universities
- Recruitment Program of Global Experts
- National Natural Science Foundation of China
Zitieren
APA
Wang, Q., Wu, Z., Yang, Y., Yang, C., Deng, H., Zhou, X., Xu, S., Wu, L., Hong, X., Yu, X., Lu, L., & Deng, L. (2025). ZBP1 pathway promotes tumor immunogenicity in the combination of anti-HER2 therapy and epigenetic therapy. Cell Reports, 44(10), 116314. https://doi.org/10.1016/j.celrep.2025.116314
Vancouver
Wang Q, Wu Z, Yang Y, Yang C, Deng H, Zhou X, et al. ZBP1 pathway promotes tumor immunogenicity in the combination of anti-HER2 therapy and epigenetic therapy. Cell Reports. 2025;44(10):116314. doi:10.1016/j.celrep.2025.116314
BibTeX
@article{Wang2025,
author = {Wang, Qishan and Wu, Zhihao and Yang, Yuanqin and Yang, Chao and Deng, Haoran and Zhou, Xingyue and Xu, Shuting and Wu, Lingling and Hong, Xiaochuan and Yu, Xueni and Lu, Lu and Deng, Liufu},
title = {ZBP1 pathway promotes tumor immunogenicity in the combination of anti-HER2 therapy and epigenetic therapy},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {10},
pages = {116314},
doi = {10.1016/j.celrep.2025.116314}
}
EUVIMED